AOD-9604 10mg

AOD-9604: A Comprehensive Overview for Biology and Medical Researchers

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment derived from the C-terminal segment (amino acids 177–191) of human growth hormone (hGH). It is modified by the addition of a tyrosine residue at the N-terminus to enhance stability and receptor interaction. Originally developed as an anti-obesity agent, AOD-9604 retains the lipolytic (fat-breakdown) activity of full-length GH but does not stimulate insulin-like growth factor 1 (IGF-1) production, thus lacking the diabetogenic side effects commonly associated with GH therapy. It is widely studied as a potential modulator of lipid metabolism, with applications in weight management, tissue repair, and metabolic health.

Chemical Structure and Exact Amino Acid Sequence

Exact Sequence:

Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Ph

Structural Features:

• N-terminal Tyrosine (Tyr): Enhances receptor binding stability and activity stability.
• Disulfide Bond: Cysteine residues at positions 7 and 14 form a disulfide bridge, conferring conformational stability crucial for biological activity.
• Lipolytic Function: This fragment acts primarily on pathways associated with fat mobilization without significant influence on IGF-1.

Chemical Modifications:

• N-terminal Tyrosine Addition: Improves receptor affinity and peptide stability.
• Disulfide Bridge Formation: Enhances structural integrity and mimics the natural conformation of GH fragments.

Mechanisms of Action

AOD-9604 exerts its effects through mechanisms that are distinct from those of full-length human growth hormone:

• Lipolysis Activation: Stimulates hormone-sensitive lipase (HSL), leading to increased breakdown of stored triglycerides into glycerol and free fatty acids, thereby reducing adipose tissue mass. (Valko et al., 2002)
• Inhibition of Lipogenesis: Downregulates enzymes involved in fat synthesis, reducing new fat deposit formation.
• Minimal IGF-1 Stimulation: Unlike GH, AOD-9604 does not significantly elevate IGF-1 levels, preventing hypertrophic side effects and hyperglycemia, which are typical GH effects.
• Cellular Regeneration Support: Evidence suggests it may enhance cellular repair mechanisms, supporting tissue regeneration and repair processes in injured tissues (Smith et al., 2017).

Current Research and Applications

In Vitro Studies:

• Lipolytic Activity: Demonstrated capability to stimulate fat breakdown in adipocyte cultures.
• Tissue Repair and Regeneration: Shown to promote cartilage and connective tissue repair in cellular models.
• Metabolic Modulation: Investigated for effects on insulin sensitivity and lipid metabolism, useful in studies of obesity and metabolic syndrome.

Clinical & Preclinical Investigations:

• Studies suggest potential in improving body composition in obese models.
• Promising data supports its use in tissue regeneration protocols without the systemic growth effects of full GH.

Future Research Directions

The versatile profile of AOD-9604 fosters numerous avenues for future exploration:

• Mechanistic Clarification: Deepening understanding of its signaling pathways, especially regarding lipolysis and cellular repair, to optimize therapeutic strategies.
• Therapeutic Development: Advancing into clinical trials for obesity, metabolic disorders, cartilage repair, and musculoskeletal health.
• Formulation Optimization: Improving stability, delivery methods, and dosing protocols for in vitro and in vivo applications.
• Synergistic Studies: Combining AOD-9604 with other anabolic or regenerative agents to enhance tissue healing and metabolic improvement.

References & Further Reading

• Giles, S., et al. (2014). “AOD-9604: A GH Fragment with Lipolytic Activity but No IGF-1 Increase.” Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2014.38.4.270
• Valko, K. E., et al. (2002). “Mechanisms underlying the lipolytic effects of AOD-9604.” Endocrinology. https://doi.org/10.1210/en.141.8.2266

Disclaimer

This information is for research and educational purposes only. AOD-9604 is not approved for human use and is intended solely for in vitro studies and experimental applications.